The use of microcapsules for high density growth of human tumor infiltrating lymphocytes and other immune reactive T cells.
The use of microcapsules to achieve high density growth of tumor infiltrating lymphocytes (TIL) and other antigen-specific human T cells is described. Whereas human T cells in suspension cultures usually do not exceed 1-2 x 10(6) cells/ml, densities approaching that found in living tissues (greater than 10(8) cells/ml) have been observed for microcapsule cultures. TIL and human peripheral blood-derived T cells can be routinely recovered from microcapsules with viabilities greater than or equal to 90%. The recovered cells retain their antigen reactivities and bear cell surface phenotypes identical to their counterparts grown in suspension culture. These findings suggest that microcapsule technology could prove valuable in generating the vast numbers of cells required for TIL therapy and other forms of adoptive immunotherapy with T cells.
Reilly
E B
EB
Department of Immunology, Damon Biotech. Inc., Needham Heights, MA 02194.
Antognetti
G
G
Wesolowski
J S
JS
Sakorafas
P
P
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D002452:Cell Count; D002455:Cell Division; D002460:Cell Line; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D008545:Melanoma / Q000276:immunology; D008722:Methods; D010641:Phenotype; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte